|
|
Scientific Program
 |
MONDAY, SEPTEMBER 22, 2008 |
| |
08.00-08.10 |
Opening Words
M. Kaste, Finland
L. Csiba, Hungary |
| |
08.10-10.30 |
Present Situation and How to Improve It
Chairs: J. Marler, USA
V.I. Skvortsova, Russia
Stroke-in-hospital
D. Bereczki, Hungary
SITS-MOST and SITS-ISTR experiences
N. Wahlgren, Sweden
Predicting and treating Thrombolysis-related brain hemorrhage
T. Brott, USA
Emerging Use of Thrombolysis in Asia
L. Wong, China
Thrombolysis in Japan
E. Mori, Japan
Telestroke
H. Audebert, Germany
How to organize your stroke services nationwide?
M. Kaste, Finland |
| |
10.30-11.00 |
Coffee Break |
| |
11.00-12.40 |
Neuroimaging - State of the Art
Chairs: A. Buchan, UK
H. Mattle, Switzerland
How to evaluate emergency CT?
R. von Kummer, Germany
MRI in acute stroke imaging
S. Davis, Australia
PET
W-D. Heiss, Germany
Ultrasound in acute stroke
L. Csiba, Hungary
Ultrasound in the future
S. Meairs, Germany |
| |
12.40-13.40 |
Lunch |
| |
13.40-15.20 |
How to Improve Recanalization Rates?
Chairs: D. Leys, France
J.C. Grotta, USA
Sonothrombolysis enhanced with bubbles
A.V. Alexandrov, USA
Mechanical devices
W.S. Smith, USA
Combined I.V. and I.A.
J.P. Broderick, USA
Basliar arterty occlusion
P.J. Lindsberg, Finland
Ultrasound thrombolysis
C.K. Holland, USA |
| |
15:20-15:50 |
Coffee Break |
| |
15.50-17.20 |
Free Communications
Chairs: B. Norrving, Sweden, Z. Nagy, Hungary |
| |
17.20-18.20 |
Posters
Chairs: U. Dirnagl, Germany
I. Fekete, Hungary
P. Trouillas, France |
|
TUESDAY, SEPTEMBER 23, 2008 |
| |
08.00-10.20 |
Neuroprotecting Agents - Is There a Future for Them?
Supported by an Unrestricted Educational Grant from Mitsubishi Tanabe Pharma Corporation
Chairs: M.A. Moskowitz, USA
T. Tatlisumak, Finland
CEPO
Supported by an Unrestricted Educational Grant from
H.Lundbeck A/S
K. Lees, UK
Citicoline
A. Davalos, Spain
MCI-186
T. Yamaguchi, Japan
DP-99
H-C. Diener, Germany
Reperfusion injury and new neuroprotective therapy in acute stroke
K. Abe, Japan
What is in the pipeline?
M. Fisher, USA
Proof of principle first before large randomized clinical trials
S. Warach, USA
How to improve the study design for neuroprotecting agents?
G. Donnan, Australia |
| |
10:20-10:50 |
Coffee Break |
| |
10:50-12:10 |
New Horizons
Chairs: H-C. Diener, Germany
A. Czlonkowska, Poland
Craniectomia - to whom and when?
S. Schwab, Germany
Hypothermia, is there a future?
R.O. Roine, Finland
Stimulation of ganglion spehopalatina
N.M. Bornstein, Israel
NeuroFlo Treatment, SENTIS trial
A. Shuaib, Canada |
| |
12:10-13:10 |
Lunch |
| |
13:10-14:10 |
ICH - Therapeutic Enigma
Chairs: M-G. Bousser, France
H. Markus, UK
Meta-analysis of factor-VII trials
T. Steiner, Germany
CLEAR-IVH
D. Hanley, USA
Is there a role for surgery - STICH trials?
D. Mendelow, UK |
| |
14:10-15:30 |
Clinical Trials
Partially Sponsored by An Unrestricted Educational Grant From Neurobiological Technologies Inc.
Chairs: A.M. Buchan, UK
M. Brainin, Austria
Desmoteplase meta-analysis
Supported by an Unrestricted Educational Grant from H.Lundbeck A/S
K. Lees, UK
IST 3
P. Sandercock, UK
Ancrod
G. del Zoppo, USA
A Wider Time Window for Regular I.V. Lysis: Towards the Results of ECASS III
W. Hacke, Germany |
| |
15:30-15:40 |
Closing Words
M. Kaste, Finland
L. Csiba, Hungary |
|
|
